Legal & General Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
248,726
+13,876
| +6% | +$69.9K | ﹤0.01% | 2169 |
|
|
2025
Q1 | $1.52M | Buy |
234,850
+2,867
| +1% | +$18.6K | ﹤0.01% | 2022 |
|
|
2024
Q4 | $1.7M | Sell |
231,983
-13,821
| -6% | -$101K | ﹤0.01% | 2044 |
|
|
2024
Q3 | $1.84M | Buy |
245,804
+2,408
| +1% | +$18K | ﹤0.01% | 2014 |
|
|
2024
Q2 | $2.17M | Sell |
243,396
-7,893
| -3% | -$70.2K | ﹤0.01% | 1916 |
|
|
2024
Q1 | $2.55M | Buy |
251,289
+6,722
| +3% | +$68.1K | ﹤0.01% | 1827 |
|
|
2023
Q4 | $2.46M | Buy |
244,567
+902
| +0.4% | +$9.07K | ﹤0.01% | 1850 |
|
|
2023
Q3 | $2.28M | Buy |
243,665
+15,682
| +7% | +$147K | ﹤0.01% | 1839 |
|
|
2023
Q2 | $5.59M | Buy |
227,983
+5,781
| +3% | +$142K | ﹤0.01% | 1398 |
|
|
2023
Q1 | $5.17M | Sell |
222,202
-137
| -0.1% | -$3.19K | ﹤0.01% | 1397 |
|
|
2022
Q4 | $5.63M | Buy |
222,339
+3,901
| +2% | +$98.7K | ﹤0.01% | 1340 |
|
|
2022
Q3 | $4.21M | Buy |
218,438
+4,181
| +2% | +$80.6K | ﹤0.01% | 1440 |
|
|
2022
Q2 | $5.46M | Buy |
214,257
+158,982
| +288% | +$4.05M | ﹤0.01% | 1367 |
|
|
2022
Q1 | $1.42M | Buy |
55,275
+315
| +0.6% | +$8.1K | ﹤0.01% | 2112 |
|
|
2021
Q4 | $2.3M | Buy |
54,960
+1,026
| +2% | +$43K | ﹤0.01% | 1975 |
|
|
2021
Q3 | $2.35M | Buy |
53,934
+9,254
| +21% | +$403K | ﹤0.01% | 1949 |
|
|
2021
Q2 | $2.11M | Buy |
44,680
+16,371
| +58% | +$774K | ﹤0.01% | 1946 |
|
|
2021
Q1 | $1.45M | Sell |
28,309
-7,851
| -22% | -$402K | ﹤0.01% | 2100 |
|
|
2020
Q4 | $967K | Buy |
36,160
+8,875
| +33% | +$237K | ﹤0.01% | 2124 |
|
|
2020
Q3 | $937K | Sell |
27,285
-1,160
| -4% | -$39.8K | ﹤0.01% | 2046 |
|
|
2020
Q2 | $1.16M | Buy |
28,445
+27,316
| +2,419% | +$1.12M | ﹤0.01% | 1930 |
|
|
2020
Q1 | $39K | Sell |
1,129
-353
| -24% | -$12.2K | ﹤0.01% | 2682 |
|
|
2019
Q4 | $19K | Buy |
+1,482
| New | +$19K | ﹤0.01% | 3205 |
|